Back to top

Analyst Blog

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

Semtech Corporation (SMTC - Snapshot Report) reported fourth-quarter 2013 earnings of 39 cents per share, surpassing the Zacks Consensus Estimate of 34 cents. Adjusted earnings per share exclude one-time items, but include stock-based compensation expense.

Revenues

Semtech’s total revenue was $150.6 million, up 44.8% year over year. Reported revenues were toward the higher end of the management’s expectation range of $146.0 million to $152.0 million.

Direct sales represented approximately 60% of total fourth-quarter revenues, while distribution brought in the balance 40%.

Bookings

In the quarter, bookings grew across all end markets and the book to bill ratio was above 1. Total bookings accounted for approximately 41% of shipments during the quarter.

Revenue by Geography

In the fourth quarter, Asia remained the largest contributor to Semtech’s revenues, with a share of around 71%. North America accounted for 17% of the revenues, with the remaining 12% coming from Europe.

Margins

Reported gross margin for the quarter was 58.4%, up 100 basis points (bps) from the year-ago quarter and down 180 bps sequentially. The sequential decrease in gross margin was due to lower IP licensing revenues compared with the prior quarter.

Semtech reported operating expenses of $67.3 million, which were 47.3% higher than the year-ago quarter’s $45.7 million. Operating margin was 8.2%, down from 11.4% in the year-ago quarter due to higher-than-expected operating expenses. As a percentage of sales, product development and engineering expenses increased from the year-ago quarter, while selling, general and administrative (SG&A) expenses declined.

Net Income

On a GAAP basis, Semtech recorded net income of $13.1 million (19 cents per share) compared with $12.4 million (19 cents per share) in the year-ago quarter and $16.6 million (25 cents per share) in the previous quarter.

On a pro forma basis, Semtech generated net income of $26.7 million compared with $15.8 million in the year-ago comparable quarter. Pro forma earnings per share came in at 39 cents compared with 24 cents in the year-ago quarter.

Balance Sheet

Semtech ended the fourth quarter with cash and cash equivalents (including temporary investments) balance of $228.2 million versus $210.0 million in the previous quarter. Accounts receivables were $69.2 million, down from $72.8 million in the prior quarter. Days sales outstanding were 43 days, up from 42 days in the last quarter.

During the quarter, cash flow from operations was $35.2 million, free cash flow was $30.0 million and capital expenditure was $5.2 million. The company spent $7.5 million to repurchase approximately 263,000 shares.

Guidance

For the first quarter of 2014, management expects revenues in the range of $154.0 million to $162.0 million. Gross profit margin is expected in the range of 59.2%–59.8% on a GAAP basis and 61.0%–61.5% on a non-GAAP basis, flat year over year.

Selling, general and administrative (SG&A) expense is expected in the range of $35.4–$35.9 million and research and development (R&D) expense is expected in the range of $32.3 million to $32.8 million on a GAAP basis. The company anticipates stock-based compensation expense of $8.8 million, intangibles amortization charges of $7.8 million, transaction and other integration related expenses of approximately $1.7 million and interest and other expense of $4.1 million.

Accordingly, based on a share count of 68.0 million, GAAP EPS is expected in the range of 17 cents to 24 cents and non-GAAP EPS is expected to be 43–49 cents.

Also, for the first quarter, the tax rate is expected to be approximately nil to 2% on a GAAP basis. Capital expenditure is expected to be approximately $10.0 million.

Our Recommendation

Semtech Corporation is a manufacturer of a wide range of analog and mixed-signal semiconductors, including Standard Semiconductor Products, Rectifier and Assembly Products and Other Products. The company reported a robust quarter with earnings beating our expectations.

In the quarter, the company performed strongly with bookings increasing across all end markets and book-to-bill ratio of above 1 reflecting strong growth. Management’s first-quarter guidance was above the analysts’ estimates, reflecting improvement in discrete analog.

We remain optimistic about the company’s long-term prospects, solid execution and its decision to reduce operating expenses going forward.

Currently, Semtech has a Zacks Rank #3 (Hold). Other stocks in the sector that have been performing well and are worth a look include RDA Microelectronics, Inc (RDA - Snapshot Report), Supertex Inc and Microchip Technology Inc. (MCHP - Analyst Report). While RDA Microelectronics and Supertex carry a Zacks Rank #1 (Strong Buy), Microchip Technology carries a Zacks Rank #2 (Buy)

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

Learn more

Start for as little as $4.50 per trade.

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
BITAUTO HOLD BITA 35.33 +14.82%
ANI PHARMACE ANIP 24.79 +14.66%
E HOUSECHINA EJ 10.99 +9.24%
CANADIAN SOL CSIQ 26.97 +7.15%
INTERNATIONA ICAGY 33.30 +5.38%